Study List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Study List
You are on Page 2559 of 2568:
2549 2550 2551 2552 2553 2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568

Clinical Studies

NCT Number Status Brief Title View
NCT00002191 A Double-Blind Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis View
NCT00002190 A Phase II Open-Label Exploratory Study of Saquinavir Zidovudine Lamivudine in HIV Infected Patients View
NCT00002189 Paclitaxel in Advanced Refractory Kaposis Sarcoma AIDS-KS A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals View
NCT00002188 A Study of ALRT1057 in Patients With AIDS-Related Kaposis Sarcoma View
NCT00002187 A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis View
NCT00002186 Double-Blind Placebo-Controlled Study Comparing the Combination of 15 SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus HSV Infections in Subjects With Acquired Immunodeficiency Syndrome AIDS View
NCT00002185 A Pilot Open-Label Phase II Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 500 Cellsmm3 View
NCT00002184 A Phase II Stratified Randomized Double-Blind Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil ADF at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors PI and Nucleoside Reverse Transcriptase Inhibitors RTI for the Treatment of HIV-Infected Patient View
NCT00002183 A Phase I Trial to Evaluate the Safety Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection View
NCT00002182 A Study of Megestrol Acetate in HIV-Infected Children View
NCT00002181 Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS View
NCT00002180 A Study of PMPA in HIV-Infected Patients View
NCT00002179 The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection View
NCT00002178 A Phase IIIB Open-Label Comparative Study to Evaluate Saquinavir Soft Gel Capsule SGC Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients View
NCT00002177 A Pilot Open Label Trial of HIV Therapy With d4T Stavudine ddI Didanosine Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection View
NCT00002176 A Pilot Open Label Trial of HIV Therapy With d4T Stavudine ddI Didanosine Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection View
NCT00002175 Epicutaneous 1-Chloro-2 4-Dinitrobenzene DNCB Patch in HIV Infection View
NCT00002174 Further Evaluation of Thalidomides Ability to Potentiate the Immune Response to HIV-Infected Patients View
NCT00002173 An Expanded Access Open Label Protocol of Remune HIV-1 Immunogen in HIV-1-Infected Adults With CD4 Count 550 Cells Ml and Greater View
NCT00002172 An Expanded Access Open-Label Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 CellsMl View
NCT00002171 A Study of Viracept in HIV-Positive Women View
NCT00002170 A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease MAC View
NCT00002169 A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis View
NCT00002168 A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients View
NCT00002167 Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposis Sarcoma Study Summary View
NCT00002166 An Open-Label Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune Nevirapine in Adult and Pediatric Patients With Progressive HIV Disease View
NCT00002165 Viracept Expanded Access Program View
NCT00002164 Phase I Study of Safety Tolerability and Pharmacokinetics of Viracept in HIV-1 Infected Children and Exposed Infants View
NCT00002163 A Phase III Randomized Double-Blind Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex View
NCT00002162 A Randomized Parallel Arm Comparative Open Label Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs View
NCT00002161 A Multi-Center Randomized Double-Blind Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts 200mm3 View
NCT00002160 A Multicenter Phase IIIII Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain View
NCT00002159 A Randomized Open Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis View
NCT00002158 A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis View
NCT00002157 Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome View
NCT00002156 A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis CMVR View
NCT00002155 A Six-Month Safety and Antiviral Study in HIV-1 Seropositive AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cellsmm3 to Evaluate MK-639 Alone Versus Zidovudine AZT and 3TC Versus the Combination of MK-639 With AZT3TC View
NCT00002154 A Study of Thioctic Acid and Deprenyl in HIV-Infected Patients With Dementia View
NCT00002153 Topical Use of 44-Dihydroxybenzophenone-24-Dinitrophenylhydrazone A-007 in the Treatment of Advanced Malignancies Including Kaposis Sarcoma and Lymphoproliferative Disorders View
NCT00002152 A Study of WF 10 IV Solution in Patients With Advanced HIV Disease View
NCT00002151 A Randomized Double-Blind Active-Controlled Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28574A in the Treatment of HIV-Infected Patients View
NCT00002150 A Study of the Safety and Efficacy of Chronically Administered MDL 28574A in the Treatment of HIV-Infected Patients View
NCT00002149 Acupuncture and Herbal Treatment of Chronic HIV Sinusitis View
NCT00002148 Parallel Group Placebo-Controlled Tolerability Safety and Efficacy Study of OPC-14117 in HIV Dementia View
NCT00002147 Use of Stealth Liposomal Doxorubicin HCl DOX-SL in the Treatment of Moderate to Severe AIDS-Related Kaposis Sarcoma View
NCT00002146 Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy A Phase IV Randomized Double-Blind Placebo-Controlled Cross-Over Pilot Study View
NCT00002145 Phase III Multicenter Open-Label Randomized Trial of Induction Versus Induction Plus Maintenance Foscarnet Foscavir Therapy for Gastrointestinal CMV Disease View
NCT00002144 The Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir Treatment View
NCT00002143 Treatment of Psoriasis Using Acitretin in HIV-Positive Patients View
NCT00002142 An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS View
NCT00002141 A Phase I Trial to Evaluate the Safety and Pharmacokinetics of 1592U89 View
NCT00002140 A Randomized Double-Blind Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex MAC Infection in AIDs Patients View
NCT00002139 Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects View
NCT00002138 A Phase I Trial of Tecogalan Sodium DS-4152 Administered as an Infusion Twice Weekly for 21 Days View
NCT00002137 A Phase I Trial of Tecogalan Sodium DS-4152 Administered as an Infusion Weekly x 4 View
NCT00002136 A Phase I Trial of Tecogalan Sodium DS-4152 Administered as an Infusion Every 21 Days View
NCT00002135 An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access View
NCT00002134 A Randomized Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis View
NCT00002133 An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects View
NCT00002132 Randomized Controlled Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis View
NCT00002131 A Pilot Study of OPC-8212 Vesnarinone in Persons With AIDS-Related Kaposis Sarcoma View
NCT00002130 A Long-Term Follow-On Safety Study of Four Doses of OPC-8212 Vesnarinone in HIV-Infected Persons View
NCT00002129 A Phase I Study of Three Doses of OPC-8212 Vesnarinone in HIV-Infected Persons With CD4 Cell Number 300 Cellsmm3 View
NCT00002128 Phase I Study of the Safety Tolerance and Pharmacokinetics of 9-2-BispivaloyloxymethylPhosphonylmethoxyethylAdenine Bis-POM PMEA Adefovir Dipivoxil in HIV-Infected Patients View
NCT00002127 A Phase II Parallel Group Randomized Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in Reducing Weight Loss in Adults With HIV Wasting Syndrome View
NCT00002126 A Randomized Controlled Multicenter Trial of Filgrastim Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor G-CSF for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection View
NCT00002125 A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir Foscarnet Sodium View
NCT00002124 A Double-Blind Randomized Dose Response Study of Three Doses of Delavirdine Mesylate U-90152S in Combination With Zidovudine ZDV Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3 View
NCT00002123 A Double-Blind Randomized Comparative Study of Delavirdine Mesylate U-90152S in Combination With Didanosine ddI Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of 300mm3 View
NCT00002122 A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex MAC and Fungal Infections in HIV-Infected Patients View
NCT00002121 Diethylhomospermine DEHSPM for Refractory AIDS-Related Diarrhea View
NCT00002120 Randomized Phase I Study of Trimetrexate Glucuronate TMTX With Leucovorin LCV Protection Plus Dapsone Versus Trimethoprim Sulfamethoxazole TMPSMX for Treatment of Moderately Severe Episodes of Pneumocystis Carinii Pneumonia View
NCT00002119 A Phase III Clinical Study of WF 10 IV Solution TCDO in Patients With HIV Infection View
NCT00002118 An Open-Label Safety Program for the Use of Zalcitabine Dideoxycytidine ddC in Pediatric Patients With Symptomatic HIV Infection Who Have Failed or Are Intolerant to AZT Monotherapy or Who Have Completed Other ddC Protocols or Are Ineligible for Other Ongoing Clinical Studies View
NCT00002117 A Randomized Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine HIVID ddC and Zidovudine AZT in Patients With HIV Infection View
NCT00002116 A Phase III Study of the Safety and Efficacy of Topical 1-S-3-Hydroxy-2-PhosphonylmethoxypropylCytosine Dihydrate Cidofovir HPMPC in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDS View
NCT00002115 A Phase III Study of the Safety Tolerance and Pharmacokinetics of 9-2-PhosphonylmethoxyethylAdenine PMEA Adefovir in Patients With Advanced HIV Disease View
NCT00002114 A Double-Blind Randomized Parallel Group Study Comparing Procysteine to Placebo in HIV-Infected Patients Who Are Taking Antiretroviral Nucleosides View
NCT00002113 A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis View
NCT00002112 Comparative Randomized Study of the Efficacy Safety and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome View
NCT00002111 A Dose-Escalating Study of Ro 31-8959 HIV Protease Inhibitor in Patients With HIV Disease View
NCT00002110 A Phase IIIII Study of Cysteamine Mercaptoethylamine and Zidovudine for the Treatment of HIV Disease View
NCT00002109 Double-Blind Study of Timunox Thymopentin in Asymptomatic HIV-Infected Patients Receiving Either Mono AZT or ddI or Combination AZT ddI or AZT ddC Anti-Retroviral Therapy View
NCT00002108 3TC Lamivudine GR109714X Open-Label Program View
NCT00002107 A Phase I Study of Subcutaneously Administered Proleukin Aldesleukin in HIV-Infected Patients View
NCT00002106 A Pilot Randomized Double-Blind Placebo-Controlled Parallel Design Multicenter Trial to Evaluate the Effect of Ranitidine on Immunologic Indicators in Asymptomatic HIV-1 Infected Subjects With a CD4 Cell Count Between 400-700 Cellsmm3 View
NCT00002105 Randomized Comparative Trial of DOX-SL Stealth Liposomal Doxorubicin Hydrochloride Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposis Sarcoma View
NCT00002104 Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium andor HIV View
NCT00002103 A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate Neutrexin With Leucovorin Protection for European Adult Patients 13 Years Old With Pneumocystis Carinii Pneumonia View
NCT00002102 A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate With Leucovorin Protection for Patients With Pneumocystis Carinii Pneumonia View
NCT00002101 A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS A ClarithromycinEthambutol Regimen Containing Rifabutin 450 Mg or Rifabutin 300 Mg or Placebo View
NCT00002100 Phase III Study of Curdlan Sulfate View
NCT00002099 Phase IIIII Study of the Tolerance and Efficacy of Combined Use of Didanosine 23-Dideoxyinosine ddI and Lentinan in HIV-Positive Patients View
NCT00002098 Phase III Study of the Tolerance and Efficacy of Combined Use of Didanosine 23-Dideoxyinosine ddI and Lentinan in HIV-Positive Patients View
NCT00002097 A Phase III Clinical Study of Nystatin IV Intravenous in Patients With HIV Infection View
NCT00002096 A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine View
NCT00002095 A Randomized Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus View
NCT00002094 Prospective Open-Label Study of the Emergence of Drug Resistance in Patients Infected With HIV-1 Who Are Taking Oral U-87201E View
NCT00002093 A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With AdriamycinBleomycinVincristine ABV in the Treatment of HIV-Associated Kaposis Sarcoma View
NCT00002092 A Study to Evaluate the Effect of Cimetidine on CD4 Lymphocyte Counts in HIV Infection View
NCT00002091 An Evaluation of Pentoxifylline in HIV-Positive Persons With Symptomatic HIV Infection and a Karnofsky Score 40 Percent and 100 Percent View
NCT00002090 An Open Multicenter Randomized Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection MAC in Patients With Acquired Immune Deficiency Syndrome AIDS View
NCT00002089 An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex MAC Infection Failing Current Therapy View
NCT00002088 Treatment of Patients With Human Immunodeficiency Virus HIV-Related Chronic Diarrhea With Saccharomyces Boulardii or Placebo A Double Blind Trial View
NCT00002087 Safety Tolerance Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals View
NCT00002086 A Randomized Trial to Evaluate the Safety and Efficacy of Combination Therapy With Retrovir AZT and HIVID ddC Versus Retrovir HIVID and Wellferon Interferon Alfa-n1 for the Treatment of HIV Infection View
NCT00002085 A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy View
NCT00002084 A Comparative Trial of Valacyclovir Hydrochloride 256U87 and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients View
NCT00002083 Intranasal Peptide T in the Treatment of Painful Peripheral Neuropathy of AIDS View
NCT00002082 Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome AIDS A Randomized Multi-Center Placebo-Controlled Double-Blind Study View
NCT00002081 Open-Label Program of Dideoxycytidine ddC to Be Used in Combination With Zidovudine AZT for Treatment of Advanced HIV Disease View
NCT00002080 Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex MAC Bacteremia in HIV Positive Patients With CD4 Counts or 200 Treatment IND Study View
NCT00002079 Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin SC-48334 and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4 Cellsmm3 NOTE Asymptomatic HIV-1 Infected Patients Also Eligible View
NCT00002078 Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus HIV Infection View
NCT00002077 An Open Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis View
NCT00002076 Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis View
NCT00002075 Multicenter Comparison of Fluconazole UK-49858 and Amphotericin B as Treatment for Acute Cryptococcal Meningitis View
NCT00002074 Multicenter Comparison of Fluconazole UK-49858 and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome View
NCT00002073 A Double-Blind Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy View
NCT00002072 A Double-Blind Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy View
NCT00002071 A Double-Blind Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy View
NCT00002070 Phase III Ganciclovir - rGM-CSF for AIDS-Related CMV Retinitis View
NCT00002069 A Study of DTC in Patients With AIDS and AIDS Related Complex View
NCT00002068 A Multicenter Comparison of Fluconazole UK-49858 and Amphotericin B as Treatment for Acute Cryptococcal Meningitis View
NCT00002067 A Study Comparing Megestrol Acetate at 800 mgDay and Placebo in AIDS Patients With Anorexia and Cachexia View
NCT00002066 Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection View
NCT00002065 Depot Disulfiram for AIDS and ARC View
NCT00002064 Toxoplasmic Encephalitis in Patients With AIDS Treatment and Prevention of Relapse View
NCT00002063 Treatment of AIDS and AIDS Related Complex Part-1- Treatment of Patients With ARC AZT Vs Placebo View
NCT00002062 Open-Label Compassionate Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised Patients View
NCT00002061 A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Immunodepressed Patients With Uncomplicated Generalized Lymphadenopathy View
NCT00002060 A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Patients With AIDS Related Complex ARC View
NCT00002059 A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed Volunteers View
NCT00002058 A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV Disease View
NCT00002057 Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC View
NCT00002056 A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral Oral Trimethoprim - Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia in AIDS View
NCT00002055 A Double-Blind Group Comparative Study To Evaluate the Long-Term Safety and Effectiveness of Two Different Doses of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients With Multiple Episodes of PCP View
NCT00002054 A Double-Blind Study To Evaluate the Long-Term Safety and Effectiveness of 60 mg Versus 120 mg of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients View
NCT00002053 A Double-Blind Placebo-Controlled Group Comparative Study To Evaluate the Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in Patients With AIDS Post First Episode PCP View
NCT00002052 Prospective Comparison of Ampicillin Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients View
NCT00002051 Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection View
NCT00002050 A Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients View
NCT00002049 Double Blind Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients View
NCT00002048 The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic CDC Group II or Have Persistent Generalized Lymphadenopathy CDC Group III View
NCT00002047 Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure View
NCT00002046 A Dose-Frequency Trial of Oral Retrovir in Patients With AIDS or Severe ARC View
NCT00002045 A Prospective Double-Blind Study of Retrovir in Early HIV Infection View
NCT00002044 A Pilot Study To Evaluate the Effect of Retrovir Zidovudine AZT in the Treatment of Human Immunodeficiency Virus HIV Associated Dementia and Neuromuscular Diseases View
NCT00002043 Dapsone 100 Mg Versus 50 as Primary Prophylaxis for Pneumocystis Carinii Pneumonia PCP in Patients With AIDS-Related Complex ARC View
NCT00002042 A Double-Blind Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS and Advanced ARC Patients With Anemia View
NCT00002041 Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients View
NCT00002040 Open Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis View
NCT00002039 An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients View
NCT00002038 Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy View
NCT00002037 Evaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare MAI Infection A Multi-Centered Pilot Study View
NCT00002036 Phase I Safety Study of Anti-HIV Immune Serum Globulin Human View
NCT00002035 Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 23-Dideoxyinosine ddI BMY-40900 for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine View
NCT00002034 A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene Ganciclovir Sodium for Cytomegalovirus Retinitis in Persons With AIDS View
NCT00002033 A Third-Party Blinded Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced Disease View
NCT00002032 Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex MAC Bacteremia in AIDS Patients With CD4 Counts or 200 A Double-Blind Placebo-Controlled Trial View
NCT00002031 Evaluation of the Epidermal Langerhans Cell Population in AIDS ARC Patients by the Topical Application of a Potent Contact Allergen 1-Chloro-24-Dinitro-Chlorobenzene DNCB View
NCT00002030 An Open Label Study to Evaluate the Long-Term Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients View
NCT00002029 Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent View
NCT00002028 A Treatment IND Investigational New Drug Protocol for the Use of Videx 23-Dideoxyinosine ddI in Patients With Acquired Immunodeficiency Syndrome AIDS or AIDS- Related Complex ARC Who Are Intolerant to Zidovudine Retrovir View
NCT00002027 Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril R64433 View
NCT00002026 Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir ACV View
NCT00002025 Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient View
NCT00002024 Ganciclovir Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections View
NCT00002023 An Oral Dose-Ranging Finding Study in Patients With HIV Disease CDC Classification Groups IIB III and IV-C2 View
NCT00002022 Treatment Program for Anemia in AIDS Patients View
NCT00002021 An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies View
NCT00002020 Trial of an Alternative Dosing Regimen of Oral Retrovir in Patients With AIDS or Advanced ARC View
NCT00002019 Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome View
NCT00002018 Double-Blind Randomized Dose Ranging Study of Alferon LDO Low Dose Oral Interferon Alfa-n3 Human Leukocyte Derived in HIV Subjects View
NCT00002017 Immunomodulation of HIV-1 Infected Individuals With PEG-Interleukin-2 View
NCT00002016 A Phase III Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody SDZ MSL-109 in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis View
NCT00002015 An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children View
NCT00002014 A Phase I Study to Evaluate the Pharmacokinetics Safety and Antiviral Effects of Concurrent Administration of Zidovudine AZT and 23-Dideoxyinosine ddI in Patients With Human Immunodeficiency Virus HIV View
NCT00002013 A Safety Pilot Pharmacokinetics and Neurocognitive Study of AS-101 in Combination With Zidovudine in AIDSARC Patients View
NCT00002012 Double-Blind Randomized Placebo-Controlled Study of Low Dose Oral Interferon Alfa-n3 Human Leukocyte Derived in ARC Patients View
NCT00002011 The Therakos UVAR Photopheresis System in the Treatment of AIDS-Related Complex View
NCT00002010 Open Non-Comparative Study of Fluconazole in Patients With Coccidioidal Meningitis View
NCT00002009 A Phase III Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia View
NCT00002008 An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia View
NCT00002007 A Pilot Trial Evaluating an Alternating Schedule of Recombinant Human GM-CSF and Azidothymidine in Patients With HIV Infection and Leukopenia View
NCT00002006 A Phase III Pilot Study of Simultaneously Administered Rhu GM-CSF CHO Cell and Azidothymidine AZT in Patients With Severe HIV Infection and Leukopenia Pharmacokinetics and Feasibility View
NCT00002005 A Phase I Study of Recombinant CD4rCD4 in Patients With AIDS and AIDS-Related Complex View
NCT00002004 A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 rCD4 in Patients With AIDS and AIDS-Related Complex View
NCT00002003 Phase II Study of NovantroneR Mitoxantrone and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas View
NCT00002002 A Randomized Double-Blind Placebo Controlled Study of l-Leucovorin in Combination With Trimethoprim Sulfamethoxazole in the Therapy of Pneumocystis Carinii Pneumonia in Patients With the Acquired Immunodeficiency Syndrome View
NCT00002001 The Antiviral Efficacy of Concurrent Zidovudine and 23-Dideoxyinosine or 23-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease View
NCT00002000 A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride 256U87 Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients View
NCT00001999 A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS View
NCT00001998 Pharmacokinetics of Nystatin LF IV in Patients With Acquired Immune Deficiency Syndrome-Related Complex ARC View
NCT00001997 Safety and Efficacy of Polyethylene Glycolated IL-2 PEG IL-2 Plus Zidovudine or Dideoxyinosine in HIV Positive Asymptomatic and Symptomatic Individuals View
NCT00001996 A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients Who Are Intolerant of Trimethoprim Sulfamethoxazole View
NCT00001995 A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex MAC Bacteremia in Patients With AIDS View
NCT00001994 A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus HIV Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine View
NCT00001993 Initial Phase II Efficacy and Safety Study of SC-48334 Administered in Combination With Low-Dose Zidovudine AZT to Symptomatic HIV-1 Infected Patients With or 200 to or 500 CD4 Cellsmm3 View
NCT00001992 A Phase I Study of the Safety and Immunogenicity of Rgp 120HIV-1IIIB Vaccine in HIV-1 Seropositive Adult Volunteers View